TORL BioTherapeutics Funding: $450M Raised, Series C (2025)
TORL BioTherapeutics is a Biotech company based in Culver City, California. It has raised $450M in total funding. Latest round: Series C.
TORL BioTherapeutics funding overview
TORL BioTherapeutics is a Biotech company based in Culver City, California. TORL BioTherapeutics has raised $450M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in October 2025. The round record for TORL BioTherapeutics runs through 2025; nothing later has been disclosed. Investors on record include Goldman Sachs Asset Management, Bristol Myers Squibb, Deep Track Capital, Vertex Ventures HC, Cowen Healthcare Investments, Alexandria Venture Investments and 5 others. 11 distinct backers are named across the disclosed rounds.
TORL BioTherapeutics at a glance
Total raised
$450M
Latest round
Series C
Latest round date
October 2025
Industry
Biotech
Headquarters
Culver City, California
Notable investors
Goldman Sachs Asset Management, Bristol Myers Squibb, Deep Track Capital, Vertex Ventures HC, Cowen Healthcare Investments, Alexandria Venture Investments, OCV Partners, Office of the Chief Investment Officer
Frequently asked about TORL BioTherapeutics funding
How much has TORL BioTherapeutics raised?
TORL BioTherapeutics has raised $450M in total disclosed funding across the rounds on record.
Who has invested in TORL BioTherapeutics?
Goldman Sachs Asset Management, Bristol Myers Squibb, Deep Track Capital, Vertex Ventures HC, Cowen Healthcare Investments, Alexandria Venture Investments are named among the investors backing TORL BioTherapeutics.
What was the latest TORL BioTherapeutics funding round?
The most recent disclosed round is a Series C, announced in October 2025.
Where is TORL BioTherapeutics based?
TORL BioTherapeutics is based in Culver City, California.
What sector does TORL BioTherapeutics operate in?
TORL BioTherapeutics is tracked under Biotech from Culver City, California, with $450M in disclosed funding.
When did TORL BioTherapeutics last raise?
The last disclosed TORL BioTherapeutics round closed in October 2025 at Series C.
Totals shown for TORL BioTherapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Culver City and the investors behind them below.
